Press release
Leading Companies Fueling Growth and Innovation in the Onychomycosis Market
Onychomycosis Market
Projected Growth of the Onychomycosis Market Through 2030
The onychomycosis market is forecasted to reach a value of $5.09 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.0%. This upward trajectory is supported by several factors, such as the rising preference for combination therapy approaches and the wider adoption of teledermatology and remote patient monitoring. Additionally, ongoing advancements in AI-assisted diagnostic tools, expansion of hospital and retail pharmacy networks, and increased investment in research targeting resistant fungal strains are contributing to the market's growth. Key trends anticipated during this period include the development of personalized antifungal treatments, more frequent use of teledermatology for diagnosis and follow-up, and enhanced awareness around nail hygiene and care.
Download a free report of the onychomycosis market report:
https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Organizations Driving the Onychomycosis Industry Forward
The competitive landscape of the onychomycosis market includes prominent companies such as Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sandoz International GmbH, Bausch Health Companies Inc., Perrigo Company plc, Galderma Laboratories LP, Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Lupin Limited, Amneal Pharmaceuticals Inc., Alembic Pharmaceuticals Inc., Kaken Pharmaceutical Co. Ltd., Mayne Pharma Group Limited, Wockhardt Ltd., Jubilant Cadista Pharmaceuticals Inc., Moberg Pharma AB, Medimetriks Pharmaceuticals Inc., Blueberry Therapeutics Ltd., Hallux Inc., NovaBiotics Ltd., and Zydus Cadila Healthcare Limited.
In a notable collaboration in July 2023, Cipher Pharmaceuticals Inc. from Canada entered into a partnership with Moberg Pharma to commercialize MOB-015, a topical treatment for nail fungus known for its superior clinical cure rates. Moberg Pharma, headquartered in Sweden, recently secured approval for this product in the European Union and plans to introduce it across 13 European countries.
Emerging Trends Impacting the Onychomycosis Market's Outlook
Growing interest in personalized antifungal therapies is reshaping how treatments are designed and delivered. Tailored therapies allow patients to receive more effective care suited to their specific infection profiles, which improves outcomes and patient satisfaction.
Meanwhile, teledermatology is becoming an important tool for diagnosing and monitoring onychomycosis cases. This technology enables remote consultations, making access to specialist care easier, especially for patients in underserved or rural regions. Furthermore, AI-powered diagnostic solutions are gaining traction by providing faster and more accurate identification of nail infections, which accelerates treatment initiation and follow-up.
View the full onychomycosis market report:
https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Detailed Breakdown of Onychomycosis Market Segments
This market is segmented in multiple ways to provide a comprehensive understanding:
1) By Type:
- Distal Subungual Onychomycosis (DSO)
- White Superficial Onychomycosis (WSO)
- Proximal Subungual Onychomycosis (PSO)
- Candida Onychomycosis
- Other Types
2) By Treatment Approach:
- Drug Treatment
- Topical Therapy
- Other Treatments
3) By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Other Distribution Channels
Further subdivisions include:
- Distal Subungual Onychomycosis (DSO) categorized into Dermatophyte Infections and Mixed Infections
- White Superficial Onychomycosis (WSO) dominated by Trichophyton Mentagrophytes Infections
- Proximal Subungual Onychomycosis (PSO) linked to Nail Psoriasis and fungal infections in immunocompromised individuals
- Candida Onychomycosis split into Candidal Nail Infections and Mixed Fungal-Candida Infections
- Other Types covering Total Nail Dystrophy and Secondary Onychomycosis
This detailed segmentation helps in understanding patient needs, treatment efficacy, and distribution efficiencies, shaping the future landscape of the onychomycosis market.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Companies Fueling Growth and Innovation in the Onychomycosis Market here
News-ID: 4483631 • Views: …
More Releases from The Business Research Company
Market Driver Insights: The Impact of Recent Advancements on the Periodontal Dis …
The periodontal disease treatment market is on track for significant expansion in the coming years. With innovations in treatment methods and growing awareness among patients, this sector is preparing to meet increasing demand and evolving healare needs. Let's explore the market's current size, key drivers, prominent players, future trends, and segmentation details to understand the trajectory of this important healare field.
Projected Growth and Market Size of the Periodontal Disease Treatment…
Peptic Ulcer Market Overview: Major Segments, Strategic Developments, and Leadin …
The peptic ulcer market is positioned for consistent advancement as healare innovations and treatment accessibility continue to improve. With ongoing developments in diagnostic tools and therapeutic options, this sector is expected to witness steady expansion over the coming years. Here is a detailed overview of the market's valuation, key players, driving trends, and segment insights shaping its future.
Projected Market Valuation and Growth Trajectory of the Peptic Ulcer Market
The peptic…
Segmentation, Major Trends, and Competitive Overview of the Pelvic Inflammatory …
The pelvic inflammatory disease (PID) treatment market is gearing up for notable expansion in the coming years. With advancements in medical therapies and growing awareness around early diagnosis, this market is set to experience steady growth and evolving treatment strategies. Let's explore the forecasted market size, key players, influential trends, and market segmentation to better understand what lies ahead.
Projected Expansion and Market Size of the Pelvic Inflammatory Disease Treatment Industry…
Leading Companies Fueling Growth and Innovation in the Pediatric Neuroblastoma T …
The pediatric neuroblastoma treatment market is poised for significant expansion as advancements in medical research and technology continue to accelerate. With a focus on innovative therapies and improved patient care, this sector is expected to experience robust growth in the coming years. Below is a detailed overview of the market's size, key players, driving factors, and emerging trends shaping its future.
Pediatric Neuroblastoma Treatment Market Size and Growth Outlook
The market…
More Releases for Onychomycosis
Rising Diabetic Population Fuels Onychomycosis Market Growth: Powering Innovatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Onychomycosis Market Through 2025?
In recent times, the onychomycosis market has experienced robust growth. It is projected to expand from $3.63 billion in 2024 to $3.83 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.4%. The growth seen in…
Rising Diabetic Population Fuels Onychomycosis Market Growth: A Significant Driv …
The Onychomycosis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Onychomycosis Market Size and Projected Growth Rate?
The market for onychomycosis has seen substantial growth in recent times. The market size is predicted to rise from $3.63 billion in 2024 to $3.83 billion…
Onychomycosis Market Insights and Development Trends
The Onychomycosis Market Is Set To Grow At An Estimated CAGR Of 8.5% From 2025 To 2034, Rising From $7.8 Billion In 2024 To $14.5 Billion By 2034.
On March 21, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Onychomycosis market goods. The market study excludes key regions that are accelerating marketization. This section also gives…
Onychomycosis Treatment Market Size & Share Analysis
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Onychomycosis Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $4.73 billion In 2028 At…
Onychomycosis Therapeutics Market - Empowering Nail Wellness, Inspiring Beautifu …
Newark, New Castle, USA - new report, titled Onychomycosis Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Onychomycosis Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Onychomycosis Therapeutics market. The report offers an overview of the market, which…
Dermatophytic Onychomycosis Therapeutics (DOT) Market
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin…
